Sherry Fox

Lynparza Receives FDA Approval With Abiraterone for Treatment of Specific Patients With Prostate Cancer

FDA Accepts New Drug Application for Tyrosine Kinase Inhibitor to Treat NSCLC Subset

Hair: A Bold, Bald Statement During Cancer

Conversations With Clinicians Make Way for MPN Symptom Control